Healthier Capital, a venture capital firm focused on advancing technology-enabled healthcare, has announced the close of its first fund at two hundred twenty million dollars. The fund was oversubscribed, reflecting strong investor interest in the firm’s approach to backing early-stage companies that operate at the intersection of healthcare delivery and modern technology. Fund participants include a diverse mix of universities, endowments, family offices, healthcare systems, and institutional investors who share a common interest in improving health outcomes through innovation.
Health Technology Insights: Mary Free Bed at Home Named Among Best Home Health Agencies 2026
The firm was created with a clear mission to support solutions that meaningfully improve health for individuals and communities. According to Amir Dan Rubin, Chief Executive Officer and Founding Managing Partner of Healthier Capital, the fund is designed to work closely with founders who use advanced technologies such as artificial intelligence and modern data platforms to solve real-world healthcare problems. Rubin explained that the firm aims to pair strong operating models with deep sector knowledge, allowing portfolio companies to scale faster and deliver both impact and long-term value.
Healthier Capital’s leadership team brings decades of hands-on experience across healthcare operations, technology, and investing. Rubin previously served as Chief Executive Officer of Amazon One Medical, following his tenure as Chair and Chief Executive Officer of One Medical through its public offering in 2020 and subsequent acquisition by Amazon in 2023. His background also includes senior executive roles at Optum within UnitedHealth Group, as well as leadership positions at Stanford Health Care, UCLA Health, and Stony Brook University Hospital. He has also been recognized twice as an EY Entrepreneur of the Year award recipient.
The broader partnership team includes Gregor Kevrekian, Aman Mahajan MD PhD, and Eric Epstein, all of whom have held leadership roles across healthcare services, venture capital, research, and education. Their combined experience spans organizations such as CVS Health, Aetna, Aetna Ventures, UPMC and UPMC Enterprises, UCLA Health and UCLA School of Medicine, Santé Ventures, McKinsey and Company, and multiple healthcare startups. This collective background informs Healthier Capital’s strategy of working closely with founders to address complex challenges across the healthcare ecosystem.
Portfolio company leaders have highlighted the firm’s operational involvement as a key differentiator. Emi Gal, Founder and Chief Executive Officer of Ezra, an AI-driven imaging company acquired in 2025 by Function Health, shared that Healthier Capital played an active role in Ezra’s growth. Gal noted that the firm provided strategic guidance at the board level, supported commercial expansion, and offered critical assistance during the acquisition process, contributing meaningfully to the company’s success.
Health Technology Insights: Lucent Health Appoints Aadam Hussain as CEO After Rodewald Retires
Healthier Capital also emphasizes long-term partnership and performance acceleration across its portfolio. Israel Krush, Chief Executive Officer of Hyro, an artificial intelligence platform company backed by Healthier Capital, said the firm’s deep understanding of healthcare technology and its broad industry network have been instrumental as Hyro expands its responsible AI agents across healthcare enterprises. Healthier Capital led Hyro’s most recent funding round and continues to support the company’s strategic direction.
Renowned scientist J. Craig Venter, a pioneer of the Human Genome Project, also commented on the firm’s role as a strategic partner. He stated that Healthier Capital’s experience across healthcare delivery, clinical research, and technology made it a strong fit to co-found and lead funding efforts for advanced genomics and diagnostics initiatives that combine AI, imaging, and sequencing to improve disease detection and treatment development.
The firm’s portfolio includes a growing group of digital health companies, one of which has already been acquired. Three portfolio companies were named to the CB Insights Digital Health 50 list for 2025, and two were finalists in the 2025 Fierce Healthcare Innovation Awards. Current investments span a wide range of healthcare needs, including conversational AI through Hyro, generative AI platforms from Qualified Health, preventive imaging via Ezra and Function Health, analytics automation at Medeloop, value-based oncology care from Daymark Health, integrated mental health services through Amae Health and Octave Health, advanced genomics at Diploid Genomics, and technology-enabled pediatric care delivered by Zarminali Pediatrics.
With its first fund now closed, Healthier Capital plans to continue building its portfolio by partnering with founders who combine strong clinical insight, scalable technology, and sustainable business models, with the shared goal of delivering measurable improvements in healthcare outcomes.
Health Technology Insights: Prescryptive and Ilant Health Expand Employer GLP-1 Access
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
